Additional eculizumab dose and tacrolimus discontinuation for treatment of COVID ‐19 in a kidney transplant recipient with aHUS-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Additional eculizumab dose and tacrolimus discontinuation for treatment of COVID ‐19 in a kidney transplant recipient with aHUS

Published:2021-07-24 Issue:1 Volume:26 Page:250-251
ISSN:1744-9979
Container-title:Therapeutic Apheresis and Dialysis
language:en
Short-container-title:Ther Apher Dial

Author:

Bašić‐Jukić Nikolina¹^ORCID,Atić Armin¹^ORCID

Affiliation:

1. Department of Nephrology, Arterial hypertension, Dialysis and Transplantation Clinical Hospital centre Zagreb Zagreb Croatia

Publisher

Wiley

Subject

Nephrology,Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1744-9987.13710

Reference11 articles.

1. COVID‐19, microangiopathy, hemostatic activation, and complement;Song WC;J Clin Invest,2020

2. COVID-19: Complement, Coagulation, and Collateral Damage

3. Complement as a target in COVID-19?

4. Atypical Hemolytic-Uremic Syndrome: An Update on Pathophysiology, Diagnosis, and Treatment

5. Atypical hemolytic uremic syndrome

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetic justification of COVID‐19 patient outcomes using DERGA, a novel data ensemble refinement greedy algorithm;Journal of Cellular and Molecular Medicine;2024-02

2. Complement and COVID-19: Three years on, what we know, what we don't know, and what we ought to know;Immunobiology;2023-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP